The global market for travel vaccines is anticipated to grow substantially. A report from the Business Research Company suggests an uptick from $5.14 billion in 2025 to potentially $7.49 billion by 2029. This projection builds upon the market's growth from $4.73 billion in 2024, and is spurred by factors such as increasing travel and tourism, the growing threat of infectious diseases, evolving government regulations, and a rising interest in exploring less common holiday destinations. View